⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL869479 | 1.00 | — | — | |
| SCHEMBL2548392 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL23036797 | 0.98 | GRIK1 (0.48) | — | |
| SCHEMBL600685 | 0.86 | GSR (0.54) | — | |
| SCHEMBL600686 | 0.86 | GSR (0.54) | — | |
| SCHEMBL2548396 | 0.86 | GSR (0.54) | — | |
| Racemethionine SCHEMBL23675421 | 0.85 | BHMT (0.45) | — | |
| SCHEMBL2546202 | 0.85 | GSR (0.57) | — | |
| SCHEMBL2548695 | 0.85 | GSR (0.57) | — | |
| SCHEMBL2546200 | 0.85 | GSR (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3297670-B1 | LINKER UNITS WITH TARGETING AND EFFECTOR ELEMENTS | IMMUNWORK INC (TW) | 2025-07-02 | — | — | EP | claimed |
| US-20250115943-A1 | SYSTEM AND METHOD FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING | FUNDAMENTAL SOLUTIONS CORP (US) | 2025-04-10 | — | — | US | claimed |
| WO-2025076510-A1 | SYSTEM AND METHOD FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING | FUNDAMENTAL SOLUTIONS CORPORATION (US) | 2025-04-10 | — | — | WO | claimed |
| EP-3344659-B1 | MOLECULAR CONSTRUCTS FOR PREVENTING THE FORMATION OF BLOOD CLOT AND/OR TREATING THROMBOSIS | IMMUNWORK INC (TW) | 2025-03-26 | — | — | EP | claimed |
| US-20250074943-A1 | DLL3 BINDING PEPTIDES AND USES THEREOF | AMGEN INC. | 2025-03-06 | — | — | US | claimed |
| WO-2024238632-A2 | ASYMMETRIC CIRCULAR TANDEM REPEAT PROTEINS | Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute (US) | 2024-11-21 | — | — | WO | claimed |
| EP-4453001-A2 | DLL3 BINDING PEPTIDES AND USES THEREOF | AMGEN INC. (US) | 2024-10-30 | — | — | EP | claimed |
| EP-4416300-A1 | ANTIBIOTIC SUSCEPTIBILITY TEST | Fundamental Solutions Corporation (US) | 2024-08-21 | — | — | EP | claimed |
| WO-2023122436-A2 | DLL3 BINDING PEPTIDES AND USES THEREOF | AMGEN INC. (US) | 2023-06-29 | — | — | WO | claimed |
| WO-2023064472-A1 | ANTIBIOTIC SUSCEPTIBILITY TEST | FUNDAMENTAL SOLUTIONS CORPORATION (US) | 2023-04-20 | — | — | WO | claimed |
| US-20230020297-A1 | UOX-ALBUMIN CONJUGATE WITH CERTAIN NUMBERS OF ALBUMIN CONJUGATED THERETO, AND MANUFACTURING METHOD THEREOF | PROABTECH CO., LTD. (KR) | 2023-01-19 | — | — | US | claimed |
| CN-108271357-B | Molecular constructs for treatment of transplant rejection | 免疫功坊股份有限公司 | 2022-06-07 | — | — | CN | claimed |
| WO-2022104001-A1 | EXPANDED PROTEIN LIBRARIES AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2022-05-19 | — | — | WO | claimed |
| US-11235064-B2 | Core constructs and their uses in configuring pharmaceutical molecules | Immunwork Inc. (TW) | 2022-02-01 | — | — | US | claimed |
| EP-3057617-B1 | NANOPARTICLE-CONTAINING HYDROGELS | AGENCY SCIENCE TECH & RES (SG) | 2020-04-01 | — | — | EP | claimed |
| EP-2773696-B1 | SELF-ASSEMBLED COMPOSITE ULTRASMALL PEPTIDE-POLYMER HYDROGELS | AGENCY SCIENCE TECH & RES (SG) | 2017-07-26 | — | — | EP | claimed |
| US-8637686-B2 | Triazole macrocycle systems | AILERON THERAPEUTICS, INC. (US) | 2014-01-28 | — | — | US | claimed |
| US-20110263815-A1 | TRIAZOLE MACROCYCLE SYSTEMS | AILERON THERAPEUTICS, INC., A DELAWARE CORPORATION (US) | 2011-10-27 | — | — | US | claimed |
| CN-122056901-A | Pharmaceutical application of harpagoside | 金陵药业股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-1998022496-A2 | ANTIVIRAL PEPTIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1998-05-28 | — | — | WO | disclosed |